The potential public health impact of new immunization strategies for the prevention of RSV in children in Panama
RSV immunization strategies would significantly reduce the disease burden in Panama. Nirsevimab would have a greater public health impact than RSVpreF due to its sustained efficacy and protection regardless of gestational age.
Authors
- Pieralessandro Lasalvia (ORCID: https://orcid.org/0000-0002-8998-6608)
- Rodrigo DeAntonio (ORCID: https://orcid.org/0000-0003-2586-4115)
- Xavier Sáez‐Llorens (ORCID: https://orcid.org/0000-0002-1149-5905)
- Paola Jaramillo
Institutions
- Secretaría Nacional de Ciencia, Tecnología e Innovación (PA)
- Hospital del Niño (PA)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1080/14737167.2025.2514530
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- AstraZeneca
- Sanofi